SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.84+0.8%Nov 10 3:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (607)9/10/2002 12:17:52 PM
From: Icebrg  Read Replies (1) of 2240
 
Medarex - Biosite

I suppose that today's announcement of an agreement between Xoma and Biosite should be a moderate positive for Medarex as Biosite is one of Medarex's development partners.

PRINCETON, N.J. and SAN DIEGO, June 1 /PRNewswire/ --
Medarex, Inc. (Nasdaq: MEDX) and Biosite Diagnostics, Inc. (Nasdaq: BSTE) today announced the launch of an alliance aimed at accelerating drug research via Trans-Phage Technology(TM). This high throughput method to create fully human antibodies combines the immunological power of Medarex's HuMAb-Mouse(TM) with the speed of Biosite's Omniclonal(TM) phage display technology. Through this alliance Biosite and Medarex will offer pharmaceutical and biotechnology companies access to large volumes of high-affinity, fully human antibodies to validate genomic targets and to identify promising drug candidates.


Whatever cloud that may have been hanging over this collaboration should now have been lifted.

Ice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext